Legal position reviewed: 9 October 2026. Prescribing update added: 6 November 2026
Thailand’s cannabis rules depend on the plant part, product and business activity. Cultivation, flower sales, extraction and finished-product manufacturing each require separate assessment. Foreign investors must also establish whether their proposed activity permits foreign ownership.
Legal status of cannabis in Thailand
Cannabis and hemp plants were removed from the Category 5 narcotics list on 9 June 2022. Their cultivation, sale and use remain subject to other controls.
Cannabis flowers are controlled herbs. Research, export, sale and commercial processing require the relevant licence under section 46 of the Protection and Promotion of Thai Traditional Medicine Wisdom Act B.E. 2542 (1999). Patient dispensing is subject to prescription requirements. June 2025 notification.
Cannabis and hemp extracts generally remain Category 5 narcotics. The principal exception covers extracts meeting all three conditions:
- THC content of no more than 0.2% by weight;
- authorised extraction; and
- production from cannabis or hemp grown in Thailand.
An extract exceeding 0.2% THC remains a narcotic even when lawfully produced from Thai-grown plants, subject to the notification’s separate exceptions for domestic seed extracts and specified analytical quality-control substances regulated as medical devices.
The notification separately exempts extracts from seeds of cannabis or hemp grown in Thailand. The 0.2% threshold concerns extracts; it does not impose a THC ceiling on cannabis flowers. 2022 Category 5 notification.
Finished products require their own regulatory assessment. Medicines, herbal products, foods and cosmetics must meet the applicable manufacturing, product-authorisation, ingredient, labelling and advertising requirements.
How the law developed
Cannabis, commonly known in Thailand as ganja, has a long history in traditional medicine. The Cannabis Act B.E. 2477, published in 1935, introduced specific restrictions. Cannabis later became a Category 5 narcotic under the Narcotics Act B.E. 2522 (1979). A 2019 amendment permitted medical and research use through a licensing framework. The current narcotics framework is the Narcotics Code B.E. 2564 (2021). Parliament’s historical record.
The June 2022 removal of the plants from the narcotics list opened the way for cultivation and a rapidly expanding dispensary market. Recreational sales grew while a comprehensive cannabis statute remained under consideration. Businesses operated under overlapping controlled-herb, public-health and product laws.
The government subsequently tightened the framework through existing legislation. Prescription-based flower dispensing took effect in June 2025, followed by stricter licensing criteria in April 2026.
On 22 September 2026, Cabinet approved a draft Cannabis Control Bill, which proposes licensing requirements for cultivation and other cannabis activities. The bill has not become law and requires further legislative approval before taking effect. Existing rules continue to apply. MOPH announcement.
Foreign ownership: cultivation, production and sales
Commercial cannabis cultivation is prohibited to foreigners under List One of the Foreign Business Act. A company growing cannabis therefore generally needs genuine Thai-majority ownership. A Foreign Business Licence cannot override this restriction, and Thai nominee shareholders are prohibited. Foreign Business Act.
Production, processing, wholesale, retail and export require separate analysis. The exact activity and product determine the foreign-business restrictions, while sector-specific licensing rules may impose additional conditions. A structure suitable for manufacturing may therefore be unsuitable for cultivation or domestic sales.
American investors must also consider the Treaty of Amity’s exceptions, including exploitation of land or natural resources and domestic trade in indigenous agricultural products. Eligibility depends on the particular business activity.
Our guide to structuring a business in Thailand explains the wider company and foreign-investment issues.
Growing cannabis and selling the harvest
DTAM’s May 2026 guidance states that cultivation itself requires no cultivation permit under the current framework. A farm selling cannabis flowers needs a section 46 sale licence. The cultivation-supplier route permits sales to authorised licensees and excludes direct sales to the public. DTAM cultivation guidance.
Before investing in a farm, establish:
- Site suitability: lawful occupation, permitted land use, landlord consent and any agricultural-reform land restrictions.
- The sales route: a properly licensed buyer and agreed quality specifications.
- Certification: the cost and timetable for DTAM Good Agricultural and Collection Practices (GACP) certification.
- Operating costs: drying, storage, trained staff, odour control, testing and records.
The June 2025 notification requires flowers sold or exported to come from DTAM-certified GACP sources. DTAM’s online cultivation guidance also mentions a laboratory certificate of analysis. Plan for GACP certification until DTAM confirms otherwise for the proposed operation.
A farm that sells its harvest becomes a licensee and must meet the applicable operating requirements. Supply agreements should address testing, rejected batches and payment before planting begins.
Who qualifies for a cannabis-flower licence?
The April 2026 regulation adds eligibility criteria for applicants seeking to sell, export or commercially process flowers.
Eligible applicants include holders of medical-facility, drug-manufacturing or sale, herbal-product manufacturing or sale, and Category 5 cannabis-extract production licences; certified folk healers; and cultivation sites supplying section 46 licensees.
For businesses dispensing to patients, three common models are:
| Model | Underlying permissions | Practical requirements |
|---|---|---|
| Clinic | Medical-facility operating and professional-manager licences | The clinic type determines the professionals and treatments permitted. |
| Pharmacy | Appropriate drug-sale licence under the Drug Act B.E. 2510 (1967) | Pharmacy premises and pharmacist-coverage requirements apply. |
| Herbal-product business | Appropriate licence under the Herbal Products Act B.E. 2562 (2019) | Applicable personnel and premises requirements; dispensing flowers still requires a ภ.ท.33 prescription. |
Each route also requires the relevant section 46 controlled-herb licence.
Applicants must establish rights to the premises, with owner consent where applicable, and provide suitable segregated storage that preserves quality and keeps flowers off the floor. At least one DTAM-trained worker must be present throughout opening hours. Professional staffing obligations under the underlying licence also apply. An efficient odour and smoke-control system is required.
The operating budget should therefore cover both professional staffing and DTAM-trained coverage, including absences and opening-hour shifts.
Dispensing, records and prohibited sales
Under the rules effective 26 June 2025, commercial flower sales are restricted to authorised licensees, with an exception for patients holding the required prescription.
Seven professional categories may prescribe within their lawful scope: medical practitioners, dentists, pharmacists, Thai traditional medicine practitioners, applied Thai traditional medicine practitioners, Chinese medicine practitioners and certified folk healers.
Form ภ.ท.33 records the diagnosis, grams per day, treatment duration and total quantity. A prescription may cover up to 30 days of treatment. The form creates no universal 30-gram allowance. Keep it at the dispensing premises for one year. DTAM prescription and retention rules.
Licensees must maintain source, use and stock records and submit the required reports. Records should allow purchases, stock movements and dispensing to be reconciled.
Online and vending-machine sales and commercial advertising are prohibited. Prohibited sales locations include religious premises, dormitories, public parks, zoos and amusement parks.
Sales for smoking on the premises are prohibited, subject to a narrow exception for specified practitioners treating their own patients. Pharmacists are excluded from that exception. A cannabis sale licence alone does not authorise a smoking lounge. June 2025 notification.
Prescribing duties from 7 November 2026
Thai Traditional Medical Council Announcement No. 81/2569, dated 6 November 2026, takes effect on 7 November 2026. It applies to Thai traditional and applied Thai traditional medicine practitioners authorised to prescribe cannabis within their professional scope.
Before each prescription, the prescribing practitioner must examine or assess the patient and have sufficient information to determine whether cannabis is appropriate. Use must be for treatment, symptom relief or another medical purpose. Prescriptions must reflect the practitioner’s own assessment and follow the prescribed forms and requirements.
Practitioners must not lend their names, signatures or licences to cannabis businesses without actually performing their professional duties. Licence rental, lending and brokering arrangements that misrepresent professional involvement are prohibited. Employment, consultancy or other contractual arrangements do not remove professional responsibility.
Telemedicine is permitted only within applicable law and professional standards. The practitioner must verify identity, assess symptoms and relevant health information, and keep auditable records. Where a patient’s condition cannot be adequately assessed remotely, cannabis must not be prescribed solely on the basis of remote information.
Patients must receive information on use, treatment duration, precautions, significant adverse effects, contraindications and risks. Examination, assessment, diagnosis, treatment and prescribing records must be retained for the periods required by law. Breaches are dealt with under the applicable professional and other legal provisions. Council announcement No. 81/2569.
Processing and export
Before investing in extraction equipment or a finished-product line, establish the product’s legal classification and the licences required for production and sale. Narcotic extracts require the applicable narcotics authorisations. Other products remain subject to their respective product laws.
Flower exports require the relevant export licence, GACP sourcing and notification of each shipment. Confirm the destination country’s import requirements and the buyer’s authority to receive the goods before agreeing delivery. Contracts should allocate responsibility for permits, testing and rejected shipments.
Renewing or buying an existing business
Existing controlled-herb licences remain valid until expiry. Renewals must meet the amended criteria. A prior suspension for breach of the applicable notification may provide grounds for refusal. April 2026 regulation.
Underlying licences have separate calendars. Drug-sale licences expire at the end of the year of issue. Herbal-product sale licences run for five years. Clinic operating licences run until 31 December of the tenth year following issue; professional-manager licences run until 31 December of the second year following issue. Annual fees are separate.
Before renewing a lease or buying a business, check:
- The licence holder, authorised activities, expiry dates and renewal eligibility.
- Inspection findings, suspensions and outstanding corrective work.
- Supplier certification, stock records and patient documentation.
- Lease rights, landlord consent and the cost of bringing the operation into compliance.
For an asset purchase, assume the buyer needs its own licences and certification unless the authority confirms otherwise in writing. The transaction documents should address failure to obtain the necessary permissions.
What could change under the draft Cannabis Control Bill?
Cabinet approved the government’s draft Cannabis Control Bill on 22 September 2026. MOPH’s announcement describes proposed licences for cultivation, production, import, export and sale, with three-year terms, alongside further medical-use and advertising controls. The bill has not become law and requires further legislative approval before taking effect. Existing rules continue to apply. MOPH announcement.
For farm investors, cultivation licensing is a significant potential change. Allow for additional approval requirements and costs when assessing a project.
A separate Cannabis and Hemp Bill proposed by Pol. Col. Tawee Sodsong and other MPs is listed for consultation from 30 September to 14 October 2026. Parliamentary consultation.
Frequently asked questions
Can a foreigner own a cannabis farm?
Commercial cultivation is restricted under List One of the Foreign Business Act. The ordinary company route requires genuine Thai-majority ownership.
Must every dispensary become a clinic?
The regulation recognises several eligible categories, including pharmacies and herbal-product licensees. Eligibility depends on the applicant and proposed activities.
Can a farm sell directly to patients?
The cultivation-supplier route permits sales to authorised licensees. Patient dispensing requires the appropriate permissions and prescription arrangements.
Does an existing licence guarantee renewal?
Renewal depends on meeting the amended criteria. Review eligibility and operating conditions before committing further capital.
Plan Your Cannabis Business or Licence Renewal
AIM Bangkok’s Thai legal team advises on business structures, cultivation and sales licensing, renewals and acquisitions. Send us your proposed activities, location and any existing licence expiry dates.